Aβ-Induced Insulin Resistance and the Effects of Insulin on the Cholesterol Synthesis Pathway and Aβ Secretion in Neural Cells

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neuroscience Bulletin

• Publication date

  2016-05-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12264-016-0034-9PMID 27207326PMCID PMC5563777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stimulation of Insulin Signaling and Inhibition of JNK-AP1 Activation Protect Cells from Amyloid-β-Induced Signaling Dysregulation and Inflammatory Response

  2014cited by this paper
• Insulin resistance, neuroinflammation, and Alzheimer’s disease

  2014cited by this paper
• Alzheimer's disease and insulin resistance: translating basic science into clinical applications.

  2013cited by this paper
• Site-specific Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids Targeting the Lys Residues*

  2013cited by this paper
• Insulin has multiple antiamyloidogenic effects on human neuronal cells.

  2013cited by this paper
• Alzheimer disease: Insulin resistance and AD—extending the translational path

  2012cited by this paper
• An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.

  2012cited by this paper
• Isoprenoids, small GTPases and Alzheimer's disease.

  2010cited by this paper
• Diabetes and insulin in regulation of brain cholesterol metabolism.

  2010cited by this paper
• Faculty Opinions recommendation of Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes.

  2010cited by this paper
• Statins Promote the Degradation of Extracellular Amyloid β-Peptide by Microglia via Stimulation of Exosome-associated Insulin-degrading Enzyme (IDE) Secretion*

  2010cited by this paper
• Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes

  2010cited by this paper
• Modulation of Cholesterol, Farnesylpyrophosphate, and Geranylgeranylpyrophosphate in Neuroblastoma SH-SY5Y-APP695 Cells: Impact on Amyloid Beta-Protein Production

  2010cited by this paper
• [Seladin-1/DHCR24: a key protein of cell homeostasis and cholesterol biosynthesis].

  2009cited by this paper
• The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid.

  2009cited by this paper
• Central leptin regulates total ceramide content and sterol regulatory element binding protein-1C proteolytic maturation in rat white adipose tissue.

  2009cited by this paper
• Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway.

  2009cited by this paper
• Down-regulation of Seladin-1 Increases BACE1 Levels and Activity through Enhanced GGA3 Depletion during Apoptosis*

  2009cited by this paper
• Lovastatin inhibits amyloid precursor protein (APP) β‐cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid rafts

  2008cited by this paper
• Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production.

  2008influential reference
• Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed

  2008cited by this paper
• Cholesterol retention in Alzheimer's brain is responsible for high β-and γ-secretase activities and Aβ production

  2008cited by this paper
• 3beta-Hydroxysteroid-delta24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis.

  2008cited by this paper
• Seladin-1/DHCR24 protects neuroblastoma cells against Aβ toxicity by increasing membrane cholesterol content

  2008cited by this paper
• Diverse roles of Rho family GTPases in neuronal development, survival, and death.

  2008cited by this paper
• Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach.

  2007cited by this paper
• Intracellular amyloid-β in Alzheimer's disease

  2007cited by this paper
• Forecasting the global burden of Alzheimer's disease

  2007cited by this paper
• The association study between DHCR24 polymorphisms and Alzheimer's disease

  2007cited by this paper
• Statins reduce amyloid-beta production through inhibition of protein isoprenylation.

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport

  2007cited by this paper
• Intracellular amyloid-beta in Alzheimer's disease.

  2007cited by this paper
• Statins Reduce Amyloid-β Production through Inhibition of Protein Isoprenylation*

  2007cited by this paper
• Isoprenoids and Alzheimer's disease: a complex relationship.

  2006cited by this paper
• Faculty Opinions recommendation of The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo.

  2006cited by this paper
• The role of seladin‐1/DHCR24 in cholesterol biosynthesis, APP processing and Aβ generation in vivo

  2006cited by this paper
• Therapeutic intervention based on protein prenylation and associated modifications

  2006cited by this paper
• Lipid and lipoprotein dysregulation in insulin resistant states.

  2006cited by this paper
• Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells.

  2005cited by this paper
• The JNK pathway as a therapeutic target for diabetes

  2005cited by this paper
• Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

  2005cited by this paper
• Role for neuronal insulin resistance in neurodegenerative diseases.

  2004cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

  2003cited by this paper
• Alzheimer's β-Amyloid Peptides Compete for Insulin Binding to the Insulin Receptor

  2002cited by this paper
• SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

  2002cited by this paper
• Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis.

  2002cited by this paper
• A cell biological perspective on Alzheimer's disease.

  2002cited by this paper
• The Amyloidogenic Pathway of Amyloid Precursor Protein (APP) Is Independent of Its Cleavage by Caspases*

  2001cited by this paper
• Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling

  2001cited by this paper
• A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Intraneuronal Abeta42 accumulation in human brain.

  2000cited by this paper
• Neurons Regulate Extracellular Levels of Amyloid β-Protein via Proteolysis by Insulin-Degrading Enzyme

  2000cited by this paper
• Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase‐dependent pathway

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?

  2000cited by this paper
• The Human DIMINUTO/DWARF1 Homolog Seladin-1 Confers Resistance to Alzheimer's Disease-Associated Neurodegeneration and Oxidative Stress

  2000cited by this paper
• The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 *

  2000cited by this paper
• INFLAMMATION AND ALZHEIMERS DISEASE

  2000cited by this paper
• Intraneuronal Aβ42 Accumulation in Human Brain

  2000cited by this paper
• A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood.

  1999cited by this paper
• Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.

  1997cited by this paper
• The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.

  1995influential reference
• Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

  1995cited by this paper
• IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase.

  1993cited by this paper
• IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells.

  1993cited by this paper
• Expression and function of IRS-1 in insulin signal transmission.

  1992cited by this paper
• Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.

  1980cited by this paper

• What Information do Systemic Pathological Changes Bring to the Diagnosis and Treatment of Alzheimer’s Disease?

  2025cites this paper
• New insight into the role of altered brain cholesterol metabolism in the pathogenesis of AD: a unifying cholesterol hypothesis and new therapeutic approach for AD.

  2025cites this paper
• Senescence-Associated Microvascular Endothelial Dysfunction: A Focus on the Blood-Brain and Blood-Retinal Barriers.

  2024cites this paper
• The potential role of transcription factor sterol regulatory element binding proteins (SREBPs) in Alzheimer's disease.

  2024cites this paper
• Regulation of cholesterol metabolism: New players for an old physiological process

  2023cites this paper
• Mechanisms of 3-Hydroxyl 3-Methylglutaryl CoA Reductase in Alzheimer’s Disease

  2023cites this paper
• Alzheimer's disease from a diabetic brain: Exploring the molecular process to determine the potential therapy target from marine sources

  2023cites this paper
• The role of DHCR24 in the pathogenesis of AD: re-cognition of the relationship between cholesterol and AD pathogenesis

  2022cites this paper
• Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer’s Disease: Current Evidence and Future Avenues

  2022cites this paper
• Glucosamine and Its Analogues as Modulators of Amyloid-β Toxicity.

  2021cites this paper
• Targeting Insulin Resistance to Treat Cognitive Dysfunction

  2021cites this paper
• Olfactory impairment in men and mice related to aging and amyloid-induced pathology

  2021cites this paper
• DHCR24 Knock-Down Induced Tau Hyperphosphorylation at Thr181, Ser199, Thr231, Ser262, Ser396 Epitopes and Inhibition of Autophagy by Overactivation of GSK3β/mTOR Signaling

  2021cites this paper
• Synergistic Effect of Statins and Abiraterone Acetate on the Growth Inhibition of Neuroblastoma via Targeting Androgen Receptor

  2021cites this paper
• Insulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses

  2021cites this paper
• Arsenic disrupts neuronal insulin signaling through increasing free PI3K-p85 and decreasing PI3K activity.

  2021cites this paper
• Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration.

  2021cites this paper
• Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease

  2020influential citation
• Icariin Attenuates Amyloid-β (Aβ)-Induced Neuronal Insulin Resistance Through PTEN Downregulation

  2020influential citation
• Alzheimer’s Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies

  2020influential citation
• Matcha Improves Metabolic Imbalance-Induced Cognitive Dysfunction

  2020influential citation
• Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer’s Disease

  2019cites this paper
• A Crosstalk Between Brain Cholesterol Oxidation and Glucose Metabolism in Alzheimer’s Disease

  2019cites this paper
• Decreased β-Cell Function is Associated with Cardiovascular Autonomic Neuropathy in Chinese Patients Newly Diagnosed with Type 2 Diabetes

  2018cites this paper
• Intracellular Fibroblast Growth Factor 14: Emerging Risk Factor for Brain Disorders

  2017cites this paper
• Aβ inhibits SREBP-2 activation through Akt inhibition

  2017cites this paper
• Thymol improves high-fat diet-induced cognitive deficits in mice via ameliorating brain insulin resistance and upregulating NRF2/HO-1 pathway

  2017cites this paper
• THE ANALYSIS OF SPATIAL MEMORY IN NLRP3-KNOCKOUT ANIMALS

  2017cites this paper
• AGEs/RAGE-Related Neurodegeneration: daf-16 as a Mediator, Insulin as an Ameliorant, and C. elegans as an Expedient Research Model.

  2017cites this paper